78 related articles for article (PubMed ID: 82582)
1. Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells.
Greene MI; Perry LL
J Immunol; 1978 Dec; 121(6):2363-6. PubMed ID: 82582
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.
Perry LL; Benacerraf B; Greene MI
J Immunol; 1978 Dec; 121(6):2144-7. PubMed ID: 82578
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the immune response to tumor antigens. X. Activation of third-order suppressor T cells that abrogate anti-tumor immune responses.
Schatten S; Drebin JA; Perry LL; Chung W; Greene MI
J Immunol; 1984 Aug; 133(2):1064-9. PubMed ID: 6234349
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen.
Carter RH; Drebin JA; Schatten S; Perry LL; Greene MI
J Immunol; 1983 Feb; 130(2):997-1002. PubMed ID: 6184410
[TBL] [Abstract][Full Text] [Related]
5. Differential antigen presentation in tumor immunity.
Schatten S; Drebin JA; Granstein RD; Greene MI
Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
[TBL] [Abstract][Full Text] [Related]
6. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
Hostetler LW; Romerdahl CA; Kripke ML
Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of cytotoxic and suppressor T cells against syngeneic tumors in the mouse.
Yamauchi K; Fujimoto S; Tada T
J Immunol; 1979 Oct; 123(4):1653-8. PubMed ID: 90095
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
Greene MI; Fujimoto S; Sehon AH
J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
12. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
Flood PM
J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
[TBL] [Abstract][Full Text] [Related]
13. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
Ptak W; Bereta M; Ptak M; Askenase PW
J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404
[TBL] [Abstract][Full Text] [Related]
14. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
15. Modulation of immune responses by suppressor T cells.
Kapp JA; Pierce CW; Theze J; Benacerraf B
Fed Proc; 1978 Aug; 37(10):2361-64. PubMed ID: 79503
[TBL] [Abstract][Full Text] [Related]
16. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
Sobotková E; Nouza K
Neoplasma; 1993; 40(2):75-80. PubMed ID: 8350958
[TBL] [Abstract][Full Text] [Related]
17. Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids.
LeGrue SJ; Ananthaswamy HN; Simcik WJ
Cancer Res; 1989 Sep; 49(17):4747-51. PubMed ID: 2474372
[TBL] [Abstract][Full Text] [Related]
18. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation.
Seeley BM; Barthel SW; To WC; Kjaergaard J; Shu S; Plautz GE
Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503
[TBL] [Abstract][Full Text] [Related]
19. Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.
Chou T; Chang AE; Shu SY
J Immunol; 1988 Apr; 140(7):2453-61. PubMed ID: 2450925
[TBL] [Abstract][Full Text] [Related]
20. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
